Pricing
Login
Home
Charts
Search
Watchlist
Products

Piramal Pharma Ltd

PPLPHARMA
₹239.30-0.15%20 Nov 2026
Reports
Pharma CRAMS

Piramal Pharma Ltd

PPLPHARMA
₹239.30
-0.15%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹31,859Cr
Close
Close Price
₹239.30
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
—
PS
Price To Sales
3.26
Revenue
Revenue
₹9,779Cr
Rev Gr TTM
Revenue Growth TTM
9.43%
PAT Gr TTM
PAT Growth TTM
-781.97%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,9592,5521,9512,2422,2042,7541,9342,0442,1402,7522,2702,617
Growth YoY
Revenue Growth YoY%
14.118.011.617.312.57.9-0.9-8.8-2.9-0.117.428.1
Expenses
ExpensesCr
1,6902,0221,7471,9001,8662,1931,8271,8851,9442,2912,0752,268
Operating Profit
Operating ProfitCr
268530204342338561107159196461195349
OPM
OPM%
13.720.810.515.215.320.45.57.89.216.78.613.3
Other Income
Other IncomeCr
43842782958988012-11610954
Interest Expense
Interest ExpenseCr
106114107108103104868289838888
Depreciation
DepreciationCr
186196185192197243197203213218224233
PBT
PBTCr
19227-4512067273-79-46-9443-782
Tax
TaxCr
912644986311935342526277
PAT
PATCr
10101-89234154-82-99-136-9-695
Growth YoY
PAT Growth YoY%
111.2102.110.1350.0-63.651.67.8-539.2-3,800.8-105.815.1105.1
NPM
NPM%
0.54.0-4.51.00.25.6-4.2-4.8-6.4-0.3-3.10.2
EPS
EPS₹
0.10.8-0.70.20.01.2-0.6-0.8-1.0-0.1-0.50.0
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,9592,5521,9512,2422,2042,7541,9342,0442,1402,7522,2702,617
Growth YoY
Revenue Growth YoY%
14.118.011.617.312.57.9-0.9-8.8-2.9-0.117.428.1
Expenses
ExpensesCr
1,6902,0221,7471,9001,8662,1931,8271,8851,9442,2912,0752,268
Operating Profit
Operating ProfitCr
268530204342338561107159196461195349
OPM
OPM%
13.720.810.515.215.320.45.57.89.216.78.613.3
Other Income
Other IncomeCr
43842782958988012-11610954
Interest Expense
Interest ExpenseCr
106114107108103104868289838888
Depreciation
DepreciationCr
186196185192197243197203213218224233
PBT
PBTCr
19227-4512067273-79-46-9443-782
Tax
TaxCr
912644986311935342526277
PAT
PATCr
10101-89234154-82-99-136-9-695
Growth YoY
PAT Growth YoY%
111.2102.110.1350.0-63.651.67.8-539.2-3,800.8-105.815.1105.1
NPM
NPM%
0.54.0-4.51.00.25.6-4.2-4.8-6.4-0.3-3.10.2
EPS
EPS₹
0.10.8-0.70.20.01.2-0.6-0.8-1.0-0.1-0.50.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6,3156,5597,0828,1719,1518,8699,779
Growth
Revenue Growth%
3.98.015.412.0-3.19.4
Expenses
ExpensesCr
4,8875,6096,4536,9757,7067,9478,578
Operating Profit
Operating ProfitCr
1,4289506281,1961,4459221,200
OPM
OPM%
22.614.58.914.615.810.412.3
Other Income
Other IncomeCr
2303202721722087459
Interest Expense
Interest ExpenseCr
163198344448422341348
Depreciation
DepreciationCr
545586677741816831888
PBT
PBTCr
949485-120179415-17623
Tax
TaxCr
11410966161324150233
PAT
PATCr
835376-1861891-326-209
Growth
PAT Growth%
-55.0-149.6109.6411.4-457.7-782.0
NPM
NPM%
13.25.7-2.60.21.0-3.7-2.1
EPS
EPS₹
13.33.2-1.50.10.7-2.5-1.6
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6,3156,5597,0828,1719,1518,8699,779
Growth
Revenue Growth%
3.98.015.412.0-3.19.4
Expenses
ExpensesCr
4,8875,6096,4536,9757,7067,9478,578
Operating Profit
Operating ProfitCr
1,4289506281,1961,4459221,200
OPM
OPM%
22.614.58.914.615.810.412.3
Other Income
Other IncomeCr
2303202721722087459
Interest Expense
Interest ExpenseCr
163198344448422341348
Depreciation
DepreciationCr
545586677741816831888
PBT
PBTCr
949485-120179415-17623
Tax
TaxCr
11410966161324150233
PAT
PATCr
835376-1861891-326-209
Growth
PAT Growth%
-55.0-149.6109.6411.4-457.7-782.0
NPM
NPM%
13.25.7-2.60.21.0-3.7-2.1
EPS
EPS₹
13.33.2-1.50.10.7-2.5-1.6
Sales CAGR
1 Year-3%
3 Years8%
5 Years7%
TTM9%
EBITDA CAGR
1 Year-36%
3 Years14%
5 Years-8%
TTM3%
Avg. ROCE
1 Year1%
3 Years4%
5 Years4%
TTM3%
CFO / EBITDA
1 Year179%
3 Years100%
5 Years93%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
9951,1861,1931,3231,3241,3271,328
Reserves
ReservesCr
4,6105,5115,5806,5886,8016,8356,814
Current Liabilities
Current LiabilitiesCr
2,4903,0333,8434,3693,7664,7585,159
Non Current Liabilities
Non Current LiabilitiesCr
2,8053,0673,9063,0313,7865,0445,214
Total Liabilities
Total LiabilitiesCr
10,90012,79714,52315,31215,67817,96518,537
Current Assets
Current AssetsCr
3,6494,0674,8355,4645,7977,1927,254
Non Current Assets
Non Current AssetsCr
7,2518,7309,6879,8479,88110,77311,284
Total Assets
Total AssetsCr
10,90012,79714,52315,31215,67817,96518,537
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
9951,1861,1931,3231,3241,3271,328
Reserves
ReservesCr
4,6105,5115,5806,5886,8016,8356,814
Current Liabilities
Current LiabilitiesCr
2,4903,0333,8434,3693,7664,7585,159
Non Current Liabilities
Non Current LiabilitiesCr
2,8053,0673,9063,0313,7865,0445,214
Total Liabilities
Total LiabilitiesCr
10,90012,79714,52315,31215,67817,96518,537
Current Assets
Current AssetsCr
3,6494,0674,8355,4645,7977,1927,254
Non Current Assets
Non Current AssetsCr
7,2518,7309,6879,8479,88110,77311,284
Total Assets
Total AssetsCr
10,90012,79714,52315,31215,67817,96518,537

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
5987664841,0058921,653
Investing Cash Flow
Investing Cash FlowCr
-4,480-1,812-1,339-434-477-826
Financing Cash Flow
Financing Cash FlowCr
3,977794818-422-441-39
Net Cash Flow
Net Cash FlowCr
94-251-37148-26788
Free Cash Flow
Free Cash FlowCr
-5-91-461294233776
CFO To PAT
CFO To PAT%
71.6203.9-259.55,637.1979.1-507.0
CFO To EBITDA
CFO To EBITDA%
41.980.777.084.061.8179.3
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
5987664841,0058921,653
Investing Cash Flow
Investing Cash FlowCr
-4,480-1,812-1,339-434-477-826
Financing Cash Flow
Financing Cash FlowCr
3,977794818-422-441-39
Net Cash Flow
Net Cash FlowCr
94-251-37148-26788
Free Cash Flow
Free Cash FlowCr
-5-91-461294233776
CFO To PAT
CFO To PAT%
71.6203.9-259.55,637.1979.1-507.0
CFO To EBITDA
CFO To EBITDA%
41.980.777.084.061.8179.3

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8,16617,05329,76318,13831,859
Price To Earnings
Price To Earnings
991.5325.4
Price To Sales
Price To Sales
1.12.13.32.03.3
Price To Book
Price To Book
1.22.23.72.23.9
EV To EBITDA
EV To EBITDA
21.517.823.624.531.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
58.253.051.053.554.752.852.8
OPM
OPM%
22.614.58.914.615.810.412.3
NPM
NPM%
13.25.7-2.60.21.0-3.7-2.1
ROCE
ROCE%
12.96.31.85.06.41.22.7
ROE
ROE%
14.95.6-2.80.21.1-4.0-2.6
ROA
ROA%
7.72.9-1.30.10.6-1.8-1.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8,16617,05329,76318,13831,859
Price To Earnings
Price To Earnings
991.5325.4
Price To Sales
Price To Sales
1.12.13.32.03.3
Price To Book
Price To Book
1.22.23.72.23.9
EV To EBITDA
EV To EBITDA
21.517.823.624.531.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
58.253.051.053.554.752.852.8
OPM
OPM%
22.614.58.914.615.810.412.3
NPM
NPM%
13.25.7-2.60.21.0-3.7-2.1
ROCE
ROCE%
12.96.31.85.06.41.22.7
ROE
ROE%
14.95.6-2.80.21.1-4.0-2.6
ROA
ROA%
7.72.9-1.30.10.6-1.8-1.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,23,98053,58938,27931,85931,38526,48318,455
Close PriceClose₹2,294.60951.051,800.70239.303,833.5020,642.001,609.30
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE92.4587.17101.2271.4758.52
Price To SalesPS15.8526.1916.143.2619.7111.4810.96
RevenueRevenueCr7,8232,0462,3719,7791,5932,3071,684
Revenue Growth TTMRev Gr TTM%23.0%-1.2%15.5%9.4%45.2%50.5%10.7%
PAT Growth TTMPAT Gr TTM%96.3%18.9%31.4%-782.0%95.8%88.4%-104.1%
Market CapitalizationMkt CapCr1,23,98053,58938,27931,85931,38526,48318,455
Close PriceClose₹2,294.60951.051,800.70239.303,833.5020,642.001,609.30
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE92.4587.17101.2271.4758.52
Price To SalesPS15.8526.1916.143.2619.7111.4810.96
RevenueRevenueCr7,8232,0462,3719,7791,5932,3071,684
Revenue Growth TTMRev Gr TTM%23.0%-1.2%15.5%9.4%45.2%50.5%10.7%
PAT Growth TTMPAT Gr TTM%96.3%18.9%31.4%-782.0%95.8%88.4%-104.1%